Tagged with Regulatory

Tunisia Jade Salhab, senior private sector development specialist at World Bank Tunisia, discusses the impact of the public-private dialogues initiated by his organization in Tunisia, and the additional measures needed to improve healthcare outcomes in Tunisia The World Bank, in response to a request from the government of Tunisia, facilitated a…

India Dilip G Shah, secretary-general of the Indian Pharmaceutical Alliance (IPA) and member of the Expert Review Committee on Access to Medicine (ATM), discusses the association’s commitment to assisting the Indian government with policies that ensure access to affordable medicines for all as well as the requirements that every candidate needs…

Poland Mirosław Wysocki, national consultant in the area of Public Health, professor at the National Institute of Public Health (NIH), the research institute responsible inter alia for health promotion and disease prevention, discusses the overwhelming challenge of shifting the nation’s healthcare mentality from a curative approach, to a prevention lifestyle system.…

Brazil Marco Fireman, vice-minister and chairman of the National Commission for the Incorporation of Technologies (CONITEC); a board that advises the Brazilian Ministry of Health on the inclusion of new health technologies in the public healthcare scheme, discusses the crucial role of civic participation in public consultations, and documents the numerous…

Poland Marcin Czech, deputy minister and undersecretary of state at the Polish Ministry of Health, provides an in-depth perspective on Poland’s drug policy framework and the new medicines policy that aims to integrate pharmacoecomonics to ensure Poland can find an efficient balance between innovative and generic treatments for long-term stability. Furthermore,…

Tunisia Mohamed Khalil Tamim, Alcon’s head of regulatory affairs Africa manages the regulatory affairs of 47 countries in Alcon’s African cluster. He explains the necessity of creating and harmonizing medical device-specific regulatory frameworks in Africa for the benefit of patients, and documents Alcon’s strategy to navigate a price-sensitive market despite its…

Ukraine Ukraine’s bold decision to outsource public procurement of medicines to international agencies to combat rampant corruption has been well received by the pharma MNCs operational in the country, but faces criticism from domestic players. “Healthcare procurement was widely considered as one of the areas most seriously altered by corruption” Tetiana…

Canada Newly appointed minister of health of Canada, The Honourable Ginette Petitpas Taylor, shares the core tenets of her mandate, the Federal government’s priorities for investment into the Canadian healthcare ecosystem, as well as the strategic significance of the life sciences industry for the country. Healthcare was a core issue on…

Poland Wojciech Kuta, editor-in-chief of Rynek Zdrowia, a leading Polish healthcare publication, discusses the interacting dynamics of the obstacles facing Polish healthcare, as the country aims to increase healthcare spending to six percent of GDP by 2025. Furthermore, he highlights the inefficient sectors of the system, moves to promote innovation and…

Poland Zszisław Sabiłło, president of the Polish Association of the Pharmaceutical Industry Employers (PZPPF), discusses the significance of the Polish generics market in terms of volume and sales market share, and highlights the obstacles that the generics ecosystem faces in light of the new reimbursement act. Furthermore, he provides insights into…

Bulgaria Gergana Semova and Petko Konakchiev, founders of PharmDedict, share an overview of the Bulgarian regulatory dynamism, the reasons why healthcare companies should continue investing in the country, and explain why PharmDedict is not only a service provider, but also a solutions provider. After having worked for several years in the…

Bulgaria Olia Vassileva, executive director at the Bulgarian Association of Pharmaceutical Wholesalers (BAPW), gives a clear explanation of the challenges facing wholesalers in Bulgaria, its current as well as future role in the healthcare system, and its true commitment towards patient safety. As an introduction, please briefly explain the main activities…